Introduction: Every year roughly 2 million babies are stillborn and 2.4 million children die within the first month of life; the majority occurring in Low- and Middle-Income countries, with infection being an important driver.
Methods: Between January 1st 2021 and 31st December 2021 women enrolled in the PROGRESS study (https://www.gbsatstgeorges.co.uk) who had a stillbirth at delivery were approached by study staff and a heart blood aspirate sample for blood culture was taken. Over the same time period infants 0-90 days of life admitted with signs of sepsis had a blood culture collected. Blood cultures were incubated for five days in a BD BactecTM machine with monitoring after every 24hrs. Gram stain was undertaken on all presumptive positive cultures. Blood agar plates were read after 18-24hrs for growth with final confirmation by biochemical tests.
Results: In 2021 a total of 2135 blood cultures were taken. 86% (n=1835) were obtained with neonates with signs of sepsis and 14% (n=300) were obtained from heart blood aspirates. 30.3% (n=91) heart blood aspirates were positive, with 56% of specimens (n=50) isolating organisms considered likely to be pathogens. In 20% of cases (n=10) the organism was confirmed to be a viridans group Streptococcus. This was the second most common organism isolated after Enterococcus spp in heart blood aspirates. In the active surveillance cohort 2.8% (n=52) isolated pathogenic organisms, of which 7.7% (n=4) were viridans group Streptococci.
Conclusions: Our results indicate a potential role for Streptococcus viridans as a common causative agent in the aetiology of neonatal sepsis and of stillbirths in Ugandan infants.